American Century Companies’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
Other funds holding TXMD
GGHC
American Century Companies's TXMD Position: Q2 2017 in Review
American Century Companies sold out of TherapeuticsMD (TXMD) in Q2 2017, closing a stake of 2,710 shares — an estimated $976K sold.
American Century Companies first reported a position in TXMD in Q2 2015 and held it in 8 quarters. The position peaked at $1.73M in Q4 2015. 117 funds tracked by Wall St. Rank hold TXMD as of Q2 2017.
- American Century Companies reported no remaining TherapeuticsMD position as of Q2 2017 after selling out during the quarter.
- American Century Companies sold 2,710 TherapeuticsMD shares in Q2 2017, an estimated $976K.
- American Century Companies first reported a position in TherapeuticsMD in Q2 2015 and held it in 8 quarters.
- American Century Companies's TherapeuticsMD position peaked at $1.73M in Q4 2015.
- 117 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2017.
Based on American Century Companies's 13F filing for Q2 2017, filed 7 Aug 2017.